Tumor immunity and autoimmunity induced by immunization with homologous DNA

Journal of Clinical Investigation

Volumn 102, Issue 6, 1998, Pages 1258-1264

  Weber, Lawrence W ^a   Bowne, Wilbur B ^a,b   Wolchok, Jedd D ^a,b   Srinivasan, Roopa ^a   Qin, Jie ^a   Moroi, Yoichi ^a   Clynes, Raphael ^b,c   Song, Ping ^a   Lewis, Jonathan J ^a,b   Houghton, Alan N ^a,b  

^a Weill Cornell Medical Center   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Differentiation; Melanoma; Tolerance; Tyrosinase; Xenogeneic

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; DIFFERENTIATION ANTIGEN; DNA; FC RECEPTOR; GLYCOPROTEIN; MONOPHENOL MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DEPIGMENTATION; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; TUMOR IMMUNITY; TUMOR REJECTION;

EID: 0032531161     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4004     Document Type: Article

References (37)

1. Pardoll, D.M. 1994. Tumour antigens. A new look for the 1990s. Nature. 369:357.
2. Houghton, A-N. 1994. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180:1-4.
3. Boyse, E.A., and L.J. Old. 1969. Some aspects of normal and abnormal cell surface genetics. Anna. Rev. Genet. 3:269-290.
4. Houghton, A.N., M. Eisinger, A.P. Albino, J.G. Cairncross, and L.J. Old. 1982. Surface antigens of melanocytes and melanomas. Markers of melanocvte differentiation and melanoma subsets. J. Exp. Med. 156:1755-1766.
5. Hearing, V.J., and K. Tsukamoto. 1991. Enzymatic control of pigmentation in mammals. FASEB J. 5:2902-2909.
6. Vijayasaradhi, S., B. Bouchard, and A.N. Houghton. 1990. The melanoma antigen gp75 is the human homologue of the mouse ft (brown) locus gene product. J. Exp. Med. 171:1375-1380.
7. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
8. Robbins, P.F., M. El-Gamil, Y. Kawakami, E. Stevens, J.R. Yannelli. and S.A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124-3126.
9. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc. Natl. Acad. Sci. USA. 91:9461-9465.
10. Song, Y.-H., E, Connor, Y. Li, B. Zorovich, P. Balducci, and N. Maclaren. 1994. The role of tyrosinase in autoimmune vitiligo. Lancet. 344:1049-1052.
11. Merimsky, O., E. Baharav, Y. Shoenfeld, S. Chaitchik, R. Tsigelman, D. Cohen-Aloro, and P. Fishman. 1996. Anti-tyrosinase antibodies in malignant melanoma. Cancer lmmunol. Immunother. 42:297-302.
12. 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest. Dermatol. 109:69-73.
13. Wang, R.-F., P.F. Robbins, Y. Kawakami. X.-Q. Kang, and S.A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-reslricted tumor-infiltrating lymphocytes. J. Exp. Med. 181: 799-804.
14. Wang, R.-F., E. Appella, Y. Kawakami, X. Kang, and S.A. Rosenberg. 1996. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184:2207-2216.
15. Kemp, E.H., D.J. Gawkrodger, P.F. Walson, and A.P. Weetman. 1997. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin. Exp. Immunol. 109:495-500.
16. Bakker, A.B., M.W. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
17. Fidler, I. J. 1973. Selection of successive tumour lines for metastasis. Nat. New Biol. 242:148-149.
18. Hara, I., Y. Takechi, and A.N. Houghton. 1995. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med. 182:1609-1614.
19. Shihahara, S., Y. Tomita, T. Sakakura, C. Nager, B. Chaudhuri, and R. Muller. 1986. Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acid Res. 14:2413-2427.
20. Ross, H., L. Weber, S. Wang, G. Piskun, R. Dyall, P. Song, Y. Takechi, J. Nikolic-Zugic, A.N. Houghton, and J.L Lewis. 1997. Priming for T cell-mediated rejection of established tumors hy cutaneous DNA immunization. Clin. Cancer Res. 3:2191-2196.
21. Naftzger, C., K. Takechi, H. Kohda, H. Hara, S. Vijayasaradhi, and A.N. Houghton. 1996. Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity. Proc. Nail. Acad. Sci. USA. 93:14809-14814.
22. Hara, I., H. Nguyen, Y. Takechi, B. Gansbacher, P.B. Chapman, and A.N. Houghton. 1995. Rejection of mouse melanoma elicited by local secretion of interleukin-2: implicating macrophages without T cells or natural killer cells in tumor rejection. Int. J. Cancer. 61:253-260.
23. Sylvestre, D.L., and J.V. Ravetch. 1994. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science. 265:1095-1098.
24. Clynes. R., Y. Takechi, Y. Moroi, A. Houghton, and J.V. Ravetch. 1998. Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA. 95:652-656.
25. + cells but have markedly decreased helper cell activity. Nature. 353:180-184.
26. Vijayasaradhi, S., Y. Xu, B. Bouchard, and A.N. Houghton. 1995. Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75. J. Cell Biol. 130:807-820.
27. Xu, Y., V. Setaluri, Y. Takechi, and A.N. Houghton. 1997. Sorting and secretion of a melanosome membrane protein, gp75/TRP1. J. Invest. Dermaiol. 109:788-795.
28. Thomson, T.M., F.X. Real, S. Murakami, C. Cordon-Cardo, L.J. Old, and A.N. Houghton. 1988. Differentiation antigens of melanocyles and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dematol. 90:459-466.
29. Wolfel, T., M. Hauer. J. Schneider, M. Serrano, C. Wolfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K.H. Meyer zum Buschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269:1281-1284.
30. Robbins, P., M. El-Gamil, Y. Li, Y. Kawakami, D. Loftus, E. Appella, and S. Rosenberg. 1996. A mutated beta-catenin gene encodes a melanomaspecific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183: 1185-1192.
31. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254: 1643-1647.
32. Old, L.J., and Y.T. Chen. 1998. New paths in human cancer serology. J. Exp. Med. 187:1163-1167.
33. Boon, T., and L.J. Old. 1997. Cancer tumor antigens. Curr. Opin. Immunol. 9:681-683.
34. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6462.
35. Stockert, E., E. Jager, Y.T. Chen, M.J. Scanlan, I. Gout. J. Karbach, M. Arand, A. Knuth, and L.J. Old. 1998. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187: 1349-1354.
36. Loftus. D.J., C. Castelli, T.M. Clay, P. Squarcina, F.M. Marincola, M.I. Nishimura, G. Parmiani, E. Appella, and L. Rivollini. 1996. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35). J. Exp. Med. 184:647-657.
37. Marincola, F.M., L. Rivoltini, M.L. Salgaller, M. Player, and S.A. Rosenberg. 1996. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence of in vivo priming by tumor cells. J. lmmunother. Emphasis Tumor Immunol. 19:266-277.